85 related articles for article (PubMed ID: 2859189)
1. Cysteamine induces a loss of tissue somatostatin-28 when measured as somatostatin-28(15-28)-like immunoreactivity but not when assessed as somatostatin-28(1-14)-like immunoreactivity: evidence for the importance of the disulfide bond for cysteamine action.
Patel YC; Pierzchala I
Endocrinology; 1985 May; 116(5):1699-702. PubMed ID: 2859189
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine-induced depletion of brain somatostatin is associated with up-regulation of cerebrocortical somatostatin receptors.
Srikant CB; Patel YC
Endocrinology; 1984 Sep; 115(3):990-5. PubMed ID: 6146517
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin-14-like antigenic sites in fixed islet D-cells are unaltered by cysteamine: a quantitative electron microscopic immunocytochemical evaluation.
Patel YC; Ravazzola M; Amherdt M; Orci L
Endocrinology; 1987 Apr; 120(4):1663-7. PubMed ID: 2881776
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tissue and releasable molecular forms of somatostatin-28[1-12]-like immunoreactivity in rat median eminence.
Charpenet G; Patel YC
Endocrinology; 1985 May; 116(5):1863-8. PubMed ID: 2859191
[TBL] [Abstract][Full Text] [Related]
5. A high molecular weight form of somatostatin-28 (1-12)-like immunoreactive substance without somatostatin-14 immunoreactivity in the rat pancreas. Evidence that somatostatin-14 synthesis can occur independently of somatostatin-28.
Patel YC
J Clin Invest; 1983 Dec; 72(6):2137-43. PubMed ID: 6139388
[TBL] [Abstract][Full Text] [Related]
6. Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine.
Sagar SM; Landry D; Millard WJ; Badger TM; Arnold MA; Martin JB
J Neurosci; 1982 Feb; 2(2):225-31. PubMed ID: 6121016
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma.
Patel YC; Ganda OP; Benoit R
J Clin Endocrinol Metab; 1983 Nov; 57(5):1048-53. PubMed ID: 6137494
[TBL] [Abstract][Full Text] [Related]
8. Effects of cysteamine administration on somatostatin biosynthesis and levels in rat hypothalamus.
Kwok RP; Cameron JL; Faller DV; Fernstrom JD
Endocrinology; 1992 Dec; 131(6):2999-3009. PubMed ID: 1359964
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
Sagar SM; Millard WJ; Martin JB; Murchison SC
Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
[TBL] [Abstract][Full Text] [Related]
10. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine can induce duodenal ulceration in rats without depletion of immunoreactive somatostatin.
Kapuscinski M; Shulkes A; Green M; Read D; MacLellan DG
Regul Pept; 1991 Nov; 36(3):391-406. PubMed ID: 1687422
[TBL] [Abstract][Full Text] [Related]
12. Hepatic metabolism of somatostatin-14 and somatostatin-28: immunochemical characterization of the metabolic fragments and comparison of cleavage sites.
Ruggere MD; Patel YC
Endocrinology; 1985 Jul; 117(1):88-96. PubMed ID: 2861082
[TBL] [Abstract][Full Text] [Related]
13. Effects of cysteamine on pro-somatostatin related peptides.
Bakhit C; Benoit R; Bloom FE
Regul Pept; 1983 May; 6(2):169-77. PubMed ID: 6192467
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine-induced reduction in gastrointestinal somatostatin: evidence for a region-specific loss in immunoreactivity.
McIntosh CH; Bakich V; Bokenfohr K; DiScala-Guenot D; Kwok YN; Brown JC
Regul Pept; 1988 Jun; 21(3-4):205-18. PubMed ID: 2901134
[TBL] [Abstract][Full Text] [Related]
15. The effects of cysteamine on thyrotropin and immunoreactive beta-endorphin secretion in the rat.
Millard WJ; Sagar SM; Badger TM; Carr DB; Arnold MA; Spindel E; Kasting NW; Martin JB
Endocrinology; 1983 Feb; 112(2):518-25. PubMed ID: 6184215
[TBL] [Abstract][Full Text] [Related]
16. Cysteamine-induced depletion of somatostatin and prolactin.
Millard WJ; Sagar SM; Martin JB
Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
[TBL] [Abstract][Full Text] [Related]
17. Peptides derived by processing of rat prosomatostatin near the amino-terminus: characterization, tissue distribution, and release.
Rabbani SN; Patel YC
Endocrinology; 1990 Apr; 126(4):2054-61. PubMed ID: 1969342
[TBL] [Abstract][Full Text] [Related]
18. Cysteamine-induced depletion of somatostatinergic systems alters potentials evoked from the rat visual cortex.
Fontanesi G; Siciliano R; Porciatti V; Bagnoli P
Vis Neurosci; 1996; 13(2):327-34. PubMed ID: 8737284
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of cysteamine on cognitive and locomotor behavior in rats: relationship to hippocampal glial pathology and somatostatin levels.
Justino L; Welner SA; Tannenbaum GS; Schipper HM
Brain Res; 1997 Jun; 761(1):127-34. PubMed ID: 9247075
[TBL] [Abstract][Full Text] [Related]
20. Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes.
Chattha GK; Beal MF
Brain Res; 1987 Jan; 401(2):359-64. PubMed ID: 3815102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
